| Oct 29 |
Neuronetics to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call
|
| Sep 19 |
Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults
|
| Sep 16 |
NeuroStar® Releases Software Upgrades to Elevate Patient Care
|
| Sep 3 |
Butterfly Network And 3 Other Stocks Under $2 Executives Are Aggressively Buying
|
| Aug 20 |
NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University
|
| Aug 15 |
Neuronetics, Inc. (NASDAQ:STIM) Just Reported, And Analysts Assigned A US$3.33 Price Target
|
| Aug 15 |
Neuronetics inks Greenbrook merger to acquire treatment centers
|
| Aug 14 |
Neuronetics Second Quarter 2024 Earnings: Misses Expectations
|
| Aug 13 |
Neuronetics Inks a New Merger Agreement With Greenbrook
|
| Aug 12 |
Dow Dips 150 Points; Monday.com Posts Upbeat Earnings
|
